Another study proved that the combination treatment of EGFR-TKIs and MDM2 inhibitors can inhibit the proliferation of tumor cells and enhance the anti-tumor effect of EGFR-TKIs (Bianco et al. 2004). This evidence concerns the gene MDM2 and neoplasm.